Japan to triple device reviewers and introduce new review system
This article was originally published in SRA
Executive Summary
The Japanese government has approved an action plan that aims to bring new medical devices onto the market faster, according to an announcement by US medtech industry association AdvaMed1,2. The plan, which will be implemented over five years, was drafted in response to a report that found that the country’s existing medical device approval process had resulted in a significant lag in the medical technologies available in Japan in comparison with the US and European markets3.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.